Turning Point Therapeutics Inc. (TPTX) PT Raised to $170 at Roth Capital, Following Clinical Trial Update Jan 29, 2021 02:26PM
Turning Point Therapeutics Inc. (TPTX) PT Raised to $140 at Roth Capital, Following Clinical Update Dec 8, 2020 03:29PM
Turning Point Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares in Public Offering of Common Stock Oct 29, 2020 04:15PM
Turning Point Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares in Public Offering of Common Stock Oct 29, 2020 04:15PM
Turning Point Therapeutics Inc. (TPTX) Prices 4.6M Share Common Offering at $87/Sh Oct 27, 2020 05:40AM


Oct 26, 2020 11:33PM Turning Point Therapeutics Announces Pricing of $400 Million Public Offering of Common Stock
Oct 26, 2020 11:33PM Turning Point Therapeutics Announces Pricing of $400 Million Public Offering of Common Stock
Oct 26, 2020 07:00AM Turning Point Therapeutics Inc. (TPTX) Announces Commencement of $400M Public Offering of Common Stock
Oct 26, 2020 07:00AM Turning Point Therapeutics Announces Commencement of Public Offering of Common Stock
Oct 26, 2020 07:00AM Turning Point Therapeutics Announces Commencement of Public Offering of Common Stock
Sep 30, 2020 09:00AM Turning Point Therapeutics to Participate in Upcoming Virtual Investor Conference
Sep 30, 2020 09:00AM Turning Point Therapeutics to Participate in Upcoming Virtual Investor Conference
Aug 19, 2020 03:42PM Turning Point Therapeutics Inc. (TPTX) PT Raised to $77 at Roth Capital, Following Drug Trial Data Release
Nov 13, 2019 04:49PM Roth Capital Starts Turning Point Therapeutics Inc. (TPTX) at Buy